VitaNova Life Sciences (VNOV) EBIT (2017 - 2026)
VitaNova Life Sciences' (VNOV) quarterly EBIT came in at -$109860.0 in Q2 2026, down 110.15% YoY from $1.1 million in Q2 2025, and down 335.09% on a QoQ basis from $46731.0 in Q1 2026.
VitaNova Life Sciences (VNOV) EBIT (2017 - 2026) Analysis & Trends
VitaNova Life Sciences (VNOV) has 10 years of EBIT data on file, last reported at -$109860.0 in Q2 2026.
- Quarterly EBIT fell 110.15% year-over-year to -$109860.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $3601.0 (down 99.7% YoY) and the FY2026 annual result came in at $3601.0, down 99.7% from the prior year.
- EBIT retreated to -$109860.0 in Q2 2026, from $46731.0 in the prior quarter.
- In the past five years, EBIT ranged from a high of $1.1 million in Q2 2025 to a low of -$109860.0 in Q2 2026.
- A 5-year average of $77751.0 and a median of $3274.0 in 2022 frame the typical range for EBIT.
- Annual changes were most pronounced in 2023 — EBIT slumped 1236.22% — and 2024, when it surged 5406.34%.
- Tracing VNOV's EBIT over 5 years: stood at $4414.0 in 2022, then plunged by 298.35% to -$8755.0 in 2023, then soared by 815.02% to $62600.0 in 2024, then jumped by 58.42% to $99170.0 in 2025, then sank by 210.78% to -$109860.0 in 2026.
- The last three EBIT figures came in at -$109860.0 (Q2 2026), $46731.0 (Q1 2026), and $99170.0 (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 100.02 Bn | 94.85 Bn | 3.69 Bn | 1.32 Bn |
| 2 | Cencora | 60.88 Bn | 58.06 Bn | 3.61 Bn | 1.12 Bn |
| 3 | Cardinal Health | 54.14 Bn | 49.29 Bn | 2.56 Bn | 729.00 Mn |
| 4 | Henry Schein | 10.05 Bn | 9.90 Bn | 1.10 Bn | 171.00 Mn |
| 5 | Akso Health | 737.16 Mn | 736.96 Mn | - | - |
| 6 | Edap Tms | 159.12 Mn | 137.58 Mn | 7.34 Mn | -8.03 Mn |
| 7 | Accendra Health | 100.85 Mn | 93.20 Mn | 263.41 Mn | -35.15 Mn |
| 8 | 111 | 32.10 Mn | -26.65 Mn | 18.18 Mn | -2.88 Mn |
| 9 | Cosmos Health | 12.73 Mn | 10.29 Mn | 1.51 Mn | -2.93 Mn |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | -109,860.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -109,860.00 |
| Jan 31, 2026 | 46,731.00 |
| Oct 31, 2025 | 99,170.00 |
| Jul 31, 2025 | -32,440.00 |
| Apr 30, 2025 | 1.08 Mn |
| Jan 31, 2025 | 108,874.00 |
| Oct 31, 2024 | 62,600.00 |
| Jul 31, 2024 | -45,414.00 |
| Apr 30, 2024 | 232,683.00 |
| Jan 31, 2024 | 5,948.00 |
| Oct 31, 2023 | -8,755.00 |
| Jul 31, 2023 | -24,247.00 |
| Apr 30, 2023 | -4,385.00 |
| Jan 31, 2023 | -17,603.00 |
| Oct 31, 2022 | 4,414.00 |
| Jul 31, 2022 | 2,134.00 |
| Apr 30, 2022 | -26,807.00 |
| Jan 31, 2022 | 24,221.00 |
| Oct 31, 2021 | -29,991.00 |
| Jul 31, 2021 | -10,486.00 |